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Abstract 
 The innate immune system is responsible for the initial response of host defense against 
pathogens. The function of innate immune cells is regulated by positive and negative signals 
mediated by activating or inhibitory cell surface immunoreceptors. However, molecular 
mechanisms regulating innate immune responses, especially by immunoreceptors, still 
remain elusive. In this study, I characterized a newly identified activating immunoreceptor 
CD300H and investigated a ligand for an inhibitory immunoreceptor, Allergin-1. 
 Recruitment of blood leukocytes to sites of infection is essential for host defense against 
infections. Circulating monocytes and neutrophils are especially important effectors for the 
initiation of inflammatory responses to microbes. The CD300 family molecules are type 1 
immunoreceptors belonging to the immunoglobulin superfamily and are encoded by seven 
genes on human chromosome 17 and nine genes on mouse chromosome 11. They are 
expressed on myeloid lineage cells, including monocytes-macrophages, granulocytes, 
dendritic cells, and mast cells, suggesting that they play an important role in innate 
immunity. 
 Our group including me identified a previously un-annotated gene encoding an 
immunoglobulin-like receptor, designated CD300H, which is the eighth member of human 
CD300 family molecules. CD300H has a short cytoplasmic tail and associates with an 
ITAM-containing adaptor, DAP12 and DAP10. CD300H is expressed on CD16+ monocytes 
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and myeloid dendritic cells. Ligation of CD300H on CD16+ monocytes with anti-CD300H 
monoclonal antibody induced production of inflammatory cytokines and neutrophil 
chemoattractants, suggesting that CD300H may play an important role in innate immune 
responses.  
 Anaphylaxis is a life-threatening allergic reaction with a rapid onset after exposure of an 
allergen. Mast cells play critical roles in allergic reaction by producing proteases, 
vasodilating substances, cytokines, and lipid mediators. Allergin-1 is an inhibitory receptor 
that contains an immunoreceptor tyrosine-based inhibitory motif (ITIM)-like domain in the 
cytoplasmic portion. It is preferentially expressed on mast cells and suppresses IgE-mediated 
mast cell-dependent anaphylaxis in mice. However, a ligand for Allergin-1 still remains 
undetermined. 
 To identify a ligand for Allergin-1, immunoprecipitation assays were performed by using a 
mouse Allergin-1 soluble protein tagged with the Flag peptide at the C-terminus 
(mAllergin-1s-3 × Flag) from a cell–lysate of human embryonic kidney cell line, HEK293T. 
Although mass spectrometry analysis showed glucose-regulated protein (GRP) 78 as a 
candidate for Allergin-1 ligand, recombinant GRP78 protein failed to bind to mAllergin-1s-3 × 
Flag protein. Thus, further studies are required to determine a ligand for Allergin-1. 
 
